s6y

Byfield Drug, Inc.

CIK
1465009

Prospectus 10

  1. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  2. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  3. S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers
  4. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  5. S-4 Registration of securities issued in business combination transactions
  6. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  7. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  8. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  9. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  10. S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers

Other 5

  1. EFFECT Notice of Effectiveness
  2. UPLOAD Letter (PDF)
  3. 15-15D Notice of suspension of duty to file reports pursuant to Section 13 and 15(d) of the Act
  4. POSASR Post-effective Amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR
  5. POSASR Post-effective Amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR